Furthermore, after adjusting or combining with other markers, higher levels of plasma GFAP displayed predictive value for risk of the development of Alzheimer’s disease and cognitive decline (Shen et al., 2023; Parvizi et al., 2022). The gene discussed is GFAP; the disease is early-onset autosomal dominant Alzheimer disease.